---
figid: PMC11669362__fimmu-15-1493877-g006
figtitle: Activation profile of the Growth hormone signaling pathway (gene expression
  via SRF, ELK1, STAT5B, CEBPD, STAT1, STAT3) in the experimental NSCLC groups of
  RECIST responders (A) and non-responders (B) to PD(L)1 ICI immunotherapy
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC11669362
filename: fimmu-15-1493877-g006.jpg
figlink: /pmc/articles/PMC11669362/figure/F6/
number: F6
caption: 'Activation profile of the Growth hormone signaling pathway (gene expression
  via SRF, ELK1, STAT5B, CEBPD, STAT1, STAT3) in the experimental NSCLC groups of
  RECIST responders (A) and non-responders (B) to PD(L)1 ICI immunotherapy. Color
  reflects the logarithm of the case-to-normal ratio (CNR) of the pathway nodes, color
  scale is given (green – upregulated, red – downregulated, white – intact). Arrows
  show molecular interactions within a pathway: green stands for activation, red for
  inhibition. PAL values were calculated for the averaged biosamples in the treatment
  responder and non-responder groups'
papertitle: 'Biomarkers of success of anti-PD-(L)1 immunotherapy for non-small cell
  lung cancer derived from RNA- and whole-exome sequencing: results of a prospective
  observational study on a cohort of 85 patients'
reftext: Elena Poddubskaya, et al. Front Immunol. 2024;15(NA).
year: '2024'
doi: 10.3389/fimmu.2024.1493877
journal_title: Frontiers in Immunology
journal_nlm_ta: Front Immunol
publisher_name: Frontiers Media SA
keywords: immune checkpoint therapy | pembrolizumab | ipilimumab | nivolumab | non-small
  cell lung cancer | RNA sequencing | gene expression biomarker | personalized medicine
automl_pathway: 0.9160858
figid_alias: PMC11669362__F6
figtype: Figure
redirect_from: /figures/PMC11669362__F6
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11669362__fimmu-15-1493877-g006.html
  '@type': Dataset
  description: 'Activation profile of the Growth hormone signaling pathway (gene expression
    via SRF, ELK1, STAT5B, CEBPD, STAT1, STAT3) in the experimental NSCLC groups of
    RECIST responders (A) and non-responders (B) to PD(L)1 ICI immunotherapy. Color
    reflects the logarithm of the case-to-normal ratio (CNR) of the pathway nodes,
    color scale is given (green – upregulated, red – downregulated, white – intact).
    Arrows show molecular interactions within a pathway: green stands for activation,
    red for inhibition. PAL values were calculated for the averaged biosamples in
    the treatment responder and non-responder groups'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PAM
  - LRIT1
  - SHCBP1
  - GHR
  - CISH
  - PTPN6
  - HSPG2
  - PLCE1
  - PLCZ1
  - PLCB1
  - PLCB2
  - PLCB3
  - PLCB4
  - PLCD1
  - PLCD3
  - PLCD4
  - PLCG1
  - PLCG2
  - IRS1
  - JAK2
  - CEBPB
  - RPS6KA1
  - RPS6KA2
  - RPS6KA3
  - RPS6KA4
  - RPS6KA5
  - RPS6KA6
  - ELK1
  - KCNH4
  - KCNH8
  - SRF
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
---
